XML 58 R46.htm IDEA: XBRL DOCUMENT v3.25.3
Shareholders’ Equity (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Aug. 01, 2025
Jul. 30, 2025
Sep. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Jun. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Proceeds from issues of common stock   $ 5,749,400              
Offering expenses   4,940,690              
Legal fees   $ 75,000              
Shares issued from vesting of restricted stock             272,516 778,310  
Weighted average share price             $ 1.68    
Shares exercise of stock options             55,000 [1] 5,569  
Weighted average share price     $ 3.10   $ 1.63   $ 3.10 $ 1.63  
Shares conversion of the Convertible Notes               335,195  
Shares vesting of restricted stock units               $ 437,546  
Treasury stock, shares     12,253,502       12,253,502   12,253,502
Treasury stock, value     $ 18,929,915       $ 18,929,915   $ 18,929,915
Share-Based Payment Arrangement, Option [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Shares exercise of stock options             27,483    
IPO [Member] | Chief Operating Officer [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Number of shares issued   26,000              
Common Stock [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Sale of shares issued   6,052,000              
Stock price per share $ 0.95 $ 0.95              
Number of shares issued 6,052,000   6,052,000            
Shares exercise of stock options       27,483   5,569      
Shares conversion of the Convertible Notes         111,732 223,463     556,623
[1] Represents the following options exercised: